Proton-Pump Inhibitor as Palliative Care for Chemotherapy-Induced Gastroesophageal Reflux Disease in Pancreatic Cancer Patients

被引:11
|
作者
Uwagawa, Tadashi [1 ]
Misawa, Takeyuki [1 ]
Iida, Tomonori [1 ]
Sakamoto, Taro [1 ]
Gocho, Takeshi [1 ]
Wakiyama, Shigeki [1 ]
Hirohara, Shoichi [1 ]
Yanaga, Katsuhiko [1 ]
机构
[1] Jikei Univ, Sch Med, Dept Surg, Tokyo, Japan
关键词
RECOMMENDATIONS; GUIDELINES; THERAPY;
D O I
10.1089/jpm.2009.0404
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Relief of adverse events induced by chemotherapy is an important issue for patients, especially those with a poor prognosis, such as with pancreatic cancer. There are no reports of the relationship between gastroesophageal reflux disease (GERD) and chemotherapy, so we investigated the incidence of chemotherapy-induced GERD in patients undergoing treatment with gemcitabine or S-1 for pancreatic cancer and the effect of sodium rabeprazole (RPZ), a proton-pump inhibitor. GERD was diagnosed in 40% of the patients according to the Frequency Scale for Symptoms of GERD score, and RBZ therapy significantly improved their symptoms.
引用
收藏
页码:815 / 818
页数:4
相关论文
共 50 条
  • [41] Potential Risks Associated With Long-term Use of Proton Pump Inhibitors and the Maintenance Treatment Modality for Patients With Mild Gastroesophageal Reflux Disease
    Kim, Seung Young
    Lee, Kwang Jae
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2024, 30 (04) : 407 - 420
  • [42] Proton pump inhibitor monotherapy and the risk of cardiovascular events in patients with gastro-esophageal reflux disease: a meta-analysis
    Sun, S.
    Cui, Z.
    Zhou, M.
    Li, R.
    Li, H.
    Zhang, S.
    Ba, Y.
    Cheng, G.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2017, 29 (02)
  • [43] Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease
    Kahrilas, Peter J.
    Hughes, Nesta
    Howden, Colin W.
    GUT, 2011, 60 (11) : 1473 - 1478
  • [44] Post-reflux swallow-induced peristaltic wave index and mean nocturnal baseline impedance predict proton pump inhibitor response in patients with reflux hypersensitivity
    Liu, Jie
    Yin, Mengqing
    Lv, Chaolan
    Wang, Wei
    Huang, Yizhou
    Tian, Jiashuang
    Wang, Bo
    Song, Gengqing
    Yu, Yue
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (11) : 2402 - 2408
  • [45] Assessment of small intestinal bacterial overgrowth and methane production in patients on chronic proton-pump inhibitor treatment: prevalence and role of rifaximin in its management in primary care
    De Bastiani, Rudi
    Lopetuso, Loris R.
    De Bastiani, Marco
    Bacchin, Paolo
    Benedetto, Edoardo
    Boscariolo, Laura
    Caneve, Rosanna
    Chesani, Fabio
    Chiumeo, Francesco
    Civic, Zinaida
    Dainese, Antonio
    De Polo, Manuela
    Disclafani, Giuseppe
    Grattagliano, Ignazio
    Mana, Ornella
    Mancuso, Maurizio
    Mastronuzzi, Tecla
    Pati, Antonino
    Pirrotta, Enzo
    Salandini, Maurizio
    Sanna, Guido
    Scoglio, Riccardo
    Severino, Pietro
    Tosetti, Cesare
    Turnava, Leyla
    Zamparella, Maria
    Elisei, Walter
    Gasbarrini, Antonio
    Tursi, Antonio
    MINERVA GASTROENTEROLOGY, 2023, : 523 - 528
  • [46] Comparison of Chemotherapy-induced Nausea and Vomiting Between Gemcitabine Plus Nab-paclitaxel Combination Chemotherapy and Gemcitabine Monotherapy in Patients With Advanced Pancreatic Cancer
    Ohata, Koichi
    Fujii, Hironori
    Sadaka, Shiori
    Kato-Hayashi, Hiroko
    Iihara, Hirotoshi
    Kobayashi, Ryo
    Uemura, Shinya
    Iwashita, Takuji
    Shimizu, Masahito
    Suzuki, Akio
    ANTICANCER RESEARCH, 2021, 41 (07) : 3643 - 3648
  • [47] A randomized controlled trial of laparoscopic Nissen fundoplication versus proton pump inhibitors for the treatment of patients with chronic gastroesophageal reflux disease (GERD): 3-year outcomes
    Anvari, Mehran
    Allen, Christopher
    Marshall, John
    Armstrong, David
    Goeree, Ron
    Ungar, Wendy
    Goldsmith, Charles
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2011, 25 (08): : 2547 - 2554
  • [48] pH-Impedance Findings and Proton Pump Inhibitors-Responsiveness in Patients With Typical Gastroesophageal Reflux Disease Symptoms in a Large Single-Center Italian Series
    Vailati, Cristian
    Mazzoleni, Giorgia
    Testoni, Pier Alberto
    Passaretti, Sandro
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2014, 48 (07) : 613 - 619
  • [49] Night-Time Symptoms and Their Impact on Sleep in Patients with Gastroesophageal Reflux Disease Who Have a Partial Response to Proton Pump Inhibitors: A Qualitative Patient Interview Study
    Ryden, Anna
    Martin, Mona
    Halling, Katarina
    Niklasson, Anna
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2013, 6 (04) : 307 - 314
  • [50] Sleep Disturbances and Refractory Gastroesophageal Reflux Disease Symptoms in Patients Receiving Once-Daily Proton Pump Inhibitors and Efficacy of Twice-Daily Rabeprazole Treatment
    Fujiwara, Yasuhiro
    Habu, Yasuki
    Ashida, Kiyoshi
    Kusano, Motoyasu
    Higuchi, Kazuhide
    Arakawa, Tetsuo
    DIGESTION, 2013, 88 (03) : 145 - 152